Quark Pharmaceuticals' Series E Round

Quark Pharmaceuticals raised a round of funding on April 14, 2008. Investors include SBI Investment.

Fremont, California, July 30, 2008 Quark Pharmaceuticals, Inc., a development-stage pharmaceutical company discovering and developing RNA interference (RNAi)-based therapeutics, today announced that i…

Articles about Quark Pharmaceuticals' Series E Round: